New study aims to unravel brain inflammation after cancer treatment
NCT ID NCT07375628
First seen Feb 01, 2026 · Last updated Jun 23, 2026 · Updated 22 times
Summary
This study will observe 10 patients receiving CAR-T therapy to understand why some develop brain inflammation (ICANS). Researchers will use brain scans and cognitive tests to compare those with severe ICANS to those with mild or no symptoms. The goal is to learn more about the condition, not to test a new drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ICANS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better predict and manage brain-related side effects from CAR-T therapy.
What could go wrong
This is a small, early-stage observational study with only 10 participants. It is not testing a treatment, so it may not lead to direct patient benefits.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.